| Literature DB >> 35309182 |
A Valent1, L Delorme1, E Roland1, C Lambe2, S Sarnacki3, P Cattan4, B Plaud1.
Abstract
POLG-related mitochondrial disease is a rare mitochondrial disorder that is potentially associated with anaesthetic complications such as propofol-related infusion syndrome. A 19-year-old man with mitochondrial DNA deletions and POLG-related disorders presented for an elective robotic Heller-Dor myotomy for the treatment of oesophageal pseudo-achalasia associated with severe gastro-oesophageal reflux. The fasting period was minimised to reduce the risk of metabolic stress. The anaesthetic technique included a rapid sequence induction with propofol and rocuronium, a remifentanil and sevoflurane-based general anaesthesia with multimodal monitoring and peri-operative lactate-free intravenous fluids with added dextrose. The patient did not experience propofol-related infusion syndrome but did have delayed tracheal extubation due to residual neuromuscular blockade requiring a second dose of sugammadex. This report demonstrates the safety of single-use, low-dose propofol in this patient group. Patients with POLG-related mitochondrial disease may be at risk of prolonged neuromuscular blockade, and appropriate dosing of neuromuscular blocking agents with monitoring of neuromuscular blockade is strongly encouraged.Entities:
Keywords: POLG; mitochondrial disease; prolonged NMB risk‐factors; propofol infusion syndrome
Year: 2022 PMID: 35309182 PMCID: PMC8918921 DOI: 10.1002/anr3.12159
Source DB: PubMed Journal: Anaesth Rep ISSN: 2637-3726